Heraeus Medical GMBH v. Biomet, Inc.

CourtDistrict Court, N.D. Indiana
DecidedSeptember 10, 2021
Docket3:20-cv-00802
StatusUnknown

This text of Heraeus Medical GMBH v. Biomet, Inc. (Heraeus Medical GMBH v. Biomet, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Heraeus Medical GMBH v. Biomet, Inc., (N.D. Ind. 2021).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION

HERAEUS MEDICAL GMBH, et al.,

Petitioners,

v. CASE NO. 3:20-CV-802-JD-MGG

BIOMET, INC. et al.,

Respondents.

OPINION AND ORDER On September 22, 2020, Petitioners Heraeus Medical GmbH and Heraeus S.A.S. filed their Application for Discovery in Aid of Foreign Litigation Pursuant to 28 U.S.C. § 1782 (“the Section 1782 Application”). This would authorize Petitioners to issue and serve subpoenas upon Respondents Zimmer Biomet Holdings, Inc., Biomet, Inc., Biomet Orthopedics LLC, Zimmer, Inc., Zimmer US, Inc., and Biomet Manufacturing, LLC. On December 7, 2020, Respondents filed their Motion Opposing Petitioners’ Application for Discovery Pursuant to 28 U.S.C. § 1782 (“the Opposition Motion”). On December 21, 2020, Petitioners filed their response to Respondents’ Opposition Motion. Respondents filed their Reply in Support of their Opposition Motion on January 4, 2021. Petitioners filed a Motion for Hearing in this matter on July 14, 2021. The undersigned held a motion hearing via video conferencing on August 18, 2021. Having reviewed the parties’ written briefs and their oral arguments, this Court GRANTS, in part, Respondents’ Opposition Motion [DE 24]. The Court DENIES Request Nos. 1-11 of the Section 1782 Application in full [DE 1] and GRANTS Request Nos. 12-14 in part.

I. RELEVANT BACKGROUND Petitioners and Respondents are both involved in the production and sale of bone cement and are competitors in the market. [DE 1 at 7, ¶ 5]. The parties have been involved in litigation since 2008—about 13 years—regarding alleged misappropriation of trade secrets in the production of bone cement, with litigation proceeding in the United States as well as various European countries. [DE 1 at 13-16]. In 2009, Petitioners

filed two contemporaneous applications for discovery pursuant to 28 U.S.C. § 1782: one in the Eastern District of Pennsylvania against Esschem (a supplier for Respondents) and the other in this Court against Biomet and Biomet Orthopedics. Petitioners filed these applications to obtain evidence in a case against Biomet, several affiliates of Biomet, and others, in Germany. Using evidence gained from these Section 1782

proceedings, the German court enjoined Biomet and affiliated European companies from manufacturing and distributing bone cements that used Petitioners’ confidential information and trade secrets. [DE 1 at 15, ¶ 32]. Since the resolution of the German case, Petitioners sued Zimmer Biomet and Biomet in the Eastern District of Pennsylvania alleging misappropriation of their

confidential information and trade secrets (“the Pennsylvania Matter”). The Pennsylvania Matter is currently stayed1 pending resolution of yet another proceeding

1 According to Petitioners, the Pennsylvania Matter was stayed at the time Petitioners filed the instant Section 1782 Application before this Court on September 22, 2020. between the parties—one before the United States International Trade Commission (“ITC”). [DE 1 at 16, ¶ 35]. Petitioners filed a complaint pursuant to 19 U.S.C. § 1337

before the ITC against thirteen Zimmer Biomet companies (Inv. No. 337-TA-1153, the “ITC Proceeding”) on March 5, 2019. [DE 1 at 16, ¶ 36]. In the ITC Proceeding, the parties produced numerous documents pursuant to a protective order. The administrative law judge (“ALJ”) in that matter issued an Initial Determination (“ID”), which is currently under review by the ITC. [DE 1 at 17, ¶¶ 37-38]. Through their instant Section 1782 Application, Petitioners request production of

fourteen categories of documents to be used in other misappropriation lawsuits currently pending before courts in France, Belgium, and Germany. The parties disagree as to the appropriateness of the requested discovery on multiple grounds, including the role of the ITC’s Protective Order in discovery related to the ongoing foreign proceedings.

II. LEGAL STANDARD 28 U.S.C. § 1782(a) states that

[t]he district court of the district in which a person resides or is found may order him to give his testimony or statement or to produce a document or other thing for use in a proceeding in a foreign or international tribunal. . . . The order may be made . . . upon the application of any interested person . . . . To the extent that the order does not prescribe otherwise, the testimony or statement shall be taken, and the document or other thing produced, in accordance with the Federal Rules of Civil Procedure.

The “twin aims” of Section 1782 are “providing efficient means of assistance to participants in international litigation in our federal courts and encouraging foreign countries by example to provide similar means of assistance to our courts.” Intel Corp. v. Advanced Micro Devices, Inc., 542 U.S. 241, 252-53 (2004).

Determining whether to grant a request under 28 U.S.C. § 1782 is a two-part analysis. See id. at 241, 264. First, an applicant must satisfy threshold requirements based on the statute: (1) the person from whom discovery is sought must reside or be found in the district of the district court to which the application is made; (2) the discovery must be for the use in a proceeding before a foreign or international tribunal; and (3) the application must be made by a foreign or international tribunal or by an

interested person. See 28 U.S.C. § 1782. After an applicant makes this threshold showing, 28 U.S.C. § 1782 “authorizes, but does not require, the District Court to provide discovery aid [to the requesting party].” Intel, 542 U.S. at 241; see also Four Pillars Enters. Co. v. Avery Dennison Corp., 308 F.3d 1075, 1078 (9th Cir. 2002) (“Congress has given the district courts broad discretion in granting judicial assistance to foreign

countries.”) (internal citation omitted). The Intel Court articulated four factors to guide courts in deciding whether to grant a request to aid in foreign litigation: (1) whether “the person from whom the discovery is sought is a participant in the foreign proceeding,” in which case, “the need for § 1782(a) aid generally is not as apparent as . . . when evidence is sought from a nonparticipant in the matter arising abroad”; (2) the “nature of the foreign tribunal, the character of the proceedings underway abroad, and the receptivity of the foreign government or the court or agency abroad to U.S. federal-court judicial assistance”; (3) whether the Section 1782 request conceals “an attempt to circumvent foreign proof-gathering restrictions or other policies of a foreign country or the United States”; and (4) whether the discovery request includes unduly intrusive or overly burdensome requests. In re Application of On Otomasyon for Judicial Assistance Pursuant to U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Intel Corp. v. Advanced Micro Devices, Inc.
542 U.S. 241 (Supreme Court, 2004)
Heraeus Kulzer GmbH v. Biomet, Inc.
633 F.3d 591 (Seventh Circuit, 2011)
In Re APPLICATION OF
3 F.3d 54 (Second Circuit, 1993)
Euromepa S.A. v. R. Esmerian, Inc.
51 F.3d 1095 (Second Circuit, 1995)
Wauchop v. Domino's Pizza, Inc.
138 F.R.D. 539 (N.D. Indiana, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
Heraeus Medical GMBH v. Biomet, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/heraeus-medical-gmbh-v-biomet-inc-innd-2021.